載入...
Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity
BACKGROUND: Persons infected with HIV often have altered lipid profiles that may be affected by antiretroviral therapies (ART). Traditional lipid measurements may be insufficient to assess cardiovascular disease (CVD) risk in this population. METHODS: We report results from 39 ART-naive participants...
Na minha lista:
| 發表在: | Antivir Ther |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5516727/ https://ncbi.nlm.nih.gov/pubmed/27740536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3091 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|